Clinical Trials Browser

OTHER × Advanced Solid Tumor × camrelizumab × Clear all

NCT05809336 2023-04-12

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

Phase 2/3 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT04282278 2021-12-10

Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor

Phase 2 Unknown

Other solid neoplasm

Advanced Solid Tumor